Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Amgen Inc., et al., Petitioners v. Sanofi, et al.
Case Number:
18-127
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Firms
Companies
Sectors & Industries:
-
January 01, 2019
Patent Cases To Watch In 2019
The courts are set to tackle key patent issues like the on-sale bar rule, standing to seek or appeal America Invents Act reviews and whether patents issued before the AIA was passed can be challenged under the law. Here's a roundup of patent cases to watch in the coming year.
-
November 21, 2018
Sanofi Tells Justices To Pass On Appeal Over Repatha IP
Sanofi-Aventis has urged the U.S. Supreme Court not to hear an appeal by Amgen Inc. of a Federal Circuit decision that revived a challenge to Amgen's patents for its cholesterol drug Repatha, arguing that Amgen hasn't at any point before contested the appellate court's written description requirement.